Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioline Diagnostici was an Italian diagnostics company focused on in vitro diagnostic and laboratory products. Publicly available business-directory records indicate the company operated in the Turin area and sold scientific/laboratory diagnostic products, while patent records show work on cancer-associated diagnostic antigens and antibodies. The most specific identifiable R&D activity linked to the company is a patented antibody-based diagnostic approach related to pancreatic ductal adenocarcinoma biomarkers. Current registry records indicate the legal entity is in liquidation, so it appears to be inactive as an operating company. Available evidence does not support an active therapeutic drug-development pipeline; the business appears to have been centered on diagnostics products and related intellectual property.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioline Diagnostici.